ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35
Published March 13, 2013 · Recall initiated: November 2, 2012
Summary
FDA records drug Class II recall D-181-2013, published March 13, 2013 and initiated November 2, 2012. Recalling firm: Bristol Myers Squibb Manufacturing Company; Status: Terminated; Reported quantity: 21 blister packs; Lot: 2E69023A, Exp. FEB 28 2015. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
What to do
Voluntary: Firm initiated · Telephone
Get an email if ABILIFY has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- ABILIFY
- Manufacturer
- Bristol Myers Squibb Manufacturing Company
- Distributor
- LA, TN, CA
- Lot
- 2E69023A, Exp. FEB 28 2015
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAbilify (aripiprazole), 15 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAAbilify (aripiprazole), 5 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAAbilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 countMay 1, 2024
- FDAAbilify (aripiprazole), 30 mg tablets, packaged in 30 count bottles, RX only, Otsuka America Pharmaceutical,May 1, 2024
- FDAMontelukast Sodium Tablets, 10 mg (base), packaged in a) 30-count tablets per bottle (NDC 68462-392-30) and b)March 13, 2013
- FDAPhilips MX 16-Slice CT Scanner System, a whole-body computed tomography X-ray system.March 6, 2013
Questions about this recall
Was ABILIFY (aripiprazole) Tablets, 30 mg, Rx only, Blister Pack of 100 tablets, Otsuka America Pharmaceutical Inc., Bristol-Myers Squibb NDC 59148-011-35 recalled?
Yes. FDA published recall D-181-2013 on March 13, 2013. Reported hazard: CGMP Deviations: A drum of Abilify 30 mg Tablets rejected during the compression stage was not segregated from the other portion of the lot and was inadvertently shipped, packaged and distributed.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: ABILIFY.